Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics

NCT06435481 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Adrenal Insufficiency

Interventions

DRUG: 3D printed chewable formulation of hydrocortisone
DRUG: Oral suspension of hydrocortisone

Sponsor

Hospital Universitari Vall d'Hebron Research Institute